WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60


Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here


Track Your Article



Ozgur Karcioglu*, Behlul Bas, Mandana Hosseinzadeh, Asghar Kolahforoush, Ilknur Simsik and Selman Yeniocak


Introduction: Fever, headache, muskuloskeletal pain are symptoms recorded commonly in patients with COVID-19. Although preferred as the first line in these conditions, nonsteroidal anti-inflammatory drugs (NSAID) are questioned the pandemic era, with the concerns of upregulation of ACE2 receptors. This review aims to shed light to this aspect of COVID-19 clinical course, with a special emphasis on the use and safety of NSAIDs in the pandemic era. Methods: Currently available literature on the nature of painful and inflammatory conditions related to COVID-19, and NSAID use was identified by searches of available databases. Usage of these agents in the management of patients with a diagnosis or suspicion of COVID-19 was addressed in the literature data found by searches of databases. The findings were presented in different subheadings. Results: There are not well-designed, population-based randomized, controlled studies demonstrating the net effects and safety situation of NSAIDS specifically in patients with a definitive or presumptive diagnosis of COVID-19. Paracetamol and the NSAID group “profens” (ibuprofen / ketoprofen / dexketoprofen / flurbiprofen) are active agents effective in all viral infections including pandemic ones. Conclusion: Safety precautions related to COVID-19 have not been supported by evidence-based studies. COVID-19 patients can benefit from effects of paracetamol and NSAIDs following specific precautions.

Keywords: COVID-19, treatment, pain management, nonsteroidal anti-inflammatory drugs, ACE2 receptors. Ibuprofen.

[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More